Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...
An orphan in Victorian England falls in with a gang of pickpockets, led by the Artful Dodger and under the direction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback